Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 38,839 | 33,140 | 70,241 | 191,602 | 11,168 |
| Marketable Securities | 60,057 | 70,632 | 23,820 | N/A | N/A |
| Receivables | 320 | 334 | 440 | 298 | 746 |
| TOTAL | $101,650 | $105,610 | $96,890 | $193,222 | $12,167 |
| Non-Current Assets | |||||
| PPE Net | 25,942 | 16,504 | 6,882 | 2,427 | 2,290 |
| Investments And Advances | 1,368 | 0 | 56,304 | 0 | 0 |
| Other Non-Current Assets | 6,568 | 9,923 | 330 | 145 | 485 |
| TOTAL | $33,878 | $26,427 | $63,516 | $2,572 | $2,774 |
| Total Assets | $135,528 | $132,037 | $160,406 | $195,794 | $14,942 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 1,787 | N/A | N/A | 400 |
| Accounts payable and accrued liabilities | 3,287 | 3,623 | 2,106 | 1,209 | 550 |
| Accrued Expenses | 6,392 | 9,363 | 5,080 | 2,163 | 1,135 |
| Other current liabilities | 397 | 319 | 246 | 251 | 120 |
| TOTAL | $12,156 | $15,113 | $7,445 | $3,636 | $2,204 |
| Non-Current Liabilities | |||||
| Long Term Debt | 34,946 | 18,436 | 0 | N/A | 400 |
| Deferred Revenues | 2,049 | 0 | N/A | 13 | N/A |
| Other Non-Current Liabilities | 1,593 | 1,773 | 826 | 522 | 563 |
| TOTAL | $38,724 | $20,350 | $944 | $522 | $963 |
| Total Liabilities | $50,880 | $35,463 | $8,389 | $4,158 | $3,168 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,357 | 2,716 | 2,697 | N/A | N/A |
| Common Shares | 340 | 278 | 276 | 271 | 17 |
| Retained earnings | -322,512 | -230,733 | -161,492 | -112,944 | -28,979 |
| Other shareholders' equity | -102 | -39 | -358 | -56 | 39,926 |
| TOTAL | $84,648 | $96,574 | $152,017 | $191,636 | $11,774 |
| Total Liabilities And Equity | $135,528 | $132,037 | $160,406 | $195,794 | $14,942 |